肠道微生物群和慢性阻塞性肺病之间的因果关系:双向的双样本孟德尔随机化研究
Wen-Jia Li1, Chen Yao2, Lu Han1
1Department of Pulmonary and Critical Care Medicine, Shenzhen Bao'an Traditional Chinese Medicine Hospital, Guangzhou University of Chinese Medicine, Shenzhen City, People's Republic of China.
International journal of chronic obstructive pulmonary disease
|September 9, 2024
概括
这项研究揭示了11种肠道细菌物种与慢性阻塞性肺病 (COPD) 有因果关系. 某些细菌可以预防COPD,而其他细菌,如Holdemanella和Marvinbryantia,会增加风险,为新疗法提供点.
科学领域:
- 微生物组研究的研究.
- 肺部医学 肺部医学
- 遗传学 是一个遗传学.
背景情况:
- 肠道微生物群在慢性阻塞性肺病 (COPD) 中的作用越来越多地被研究.
- 肠道微生物群和COPD之间的因果关系尚不清楚.
- 这项研究调查了肠道微生物群是否影响COPD的发展.
研究的目的:
- 确定肠道微生物群和COPD之间的因果关系.
- 为了识别与COPD风险或保护相关的特定肠道细菌.
- 为COPD的临床诊断和治疗提供见解.
主要方法:
- 在全基因组关联研究 (GWAS) 数据上利用双向门德尔随机化 (MR) 分析.
- 采用了MR-Egger回归,逆方差加权 (IVW) 和加权中位数方法.
- 进行异质性和敏感性分析,以确保结果的可靠性.
主要成果:
- 确定了11种与COPD相关的肠道微生物群物种.
- 细菌菌,科林塞拉和其他物种显示出对COPD的保护作用.
- 霍尔德曼尼拉菌和马文布兰蒂亚菌被确定为风险因素,分别增加了COPD风险的1.14倍和1.15倍.
- 反向MR分析没有发现COPD与肠道微生物群的因果关系.
结论:
- 确定了11种肠道微生物群和COPD之间的因果关系.
- 这些发现为新型COPD疗法提供了潜在的目标.
- 需要进一步的临床研究来确认机制和治疗潜力.
相关概念视频
Introduction to the Human Microbiota
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota of the Respiratory Tract
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...


